Fig. 2From: A personal acquisition time regimen of 68Ga-DOTATATE total-body PET/CT in patients with neuroendocrine tumor (NET): a feasibility studyThe SNRL (a) and SNRnorm (b) against acquisition time of full-activity cohort. ns, no significant differenceBack to article page